| CT | calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ... |
|---|---|
| FC | fasciculus cuneatus; fast component [of a neuron]; febrile convulsions; feline conjunctivitis; ferri... |
| cholera-red reaction | A test for cholera vibrio whereby the addition of 3 or 4 drops of sulfuric acid (concentrated, chemically pure) to an 18-hour-old bouillon or peptone culture of the organism produces a colour from rose-pink to claret. (05 Mar 2000) |
|---|---|
| cholera sicca | An old term for a malignant form of disease seen during epidemics of Asiatic cholera in which death occurs without diarrhoea. (05 Mar 2000) |
| cholera toxin | <protein> A multimeric protein toxin from Cholera vibrio. The toxic A subunit activates adenyl cyclase irreversibly by ADP ribosylation of a Gs protein. The B subunit facilitates passage of the A subunit across the cell membrane. (18 Nov 1997) |
| cholera toxin, B subunit-horseradish peroxidase | <chemical> Conjugate of horseradish peroxidase and cholera toxin Synonym: bhrp, horseradish peroxidase-cholera toxin b subunit, cholera toxin-horseradish peroxidase, horseradish peroxidase-cholera toxin, ib4-hrp (26 Jun 1999) |
| cholera vaccine | A killed bacteria vaccine containing equal portions of the inaba and ogawa strains of vibrio cholerae, used for immunization against cholera. It enhances protection in adults for about six months, but does not reduce faecal shedding of bacteria or reduce disease transmission. Other cholera vaccines are under development. (12 Dec 1998) |
| typhoid cholera | Old term for cholera with predominantly cerebral manifestations such as confusion or dementia. (05 Mar 2000) |
| fowl cholera | A destructive disease of domestic fowls caused by Pasteurella multocida. (05 Mar 2000) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |